Discount

Anti Ccp (Anti Cyclic Cirullinated Peptide) Clia

Original price was: ₹750.00.Current price is: ₹500.00.

The Anti-CCP CLIA Test is a highly specific blood test used primarily to help diagnose Rheumatoid Arthritis (RA). It detects autoantibodies that target citrullinated peptides, which are often present in the joints of RA patients. This test is more specific than the Rheumatoid Factor (RF) test and can detect the disease at a very early stage, even before symptoms become severe.

SKU: GD60 Category:

Description

Overview: Anti-Cyclic Citrullinated Peptide (Anti-CCP) antibodies are a type of autoantibody produced by the immune system that mistakenly attacks the body’s own tissues, specifically targeting citrullinated peptides found in the joints. The CLIA (Chemiluminescence Immunoassay) method is a highly sensitive and fully automated technique used to detect and quantify these antibodies in your blood.

Clinical Significance: The Anti-CCP test is considered a cornerstone in the diagnosis and management of Rheumatoid Arthritis (RA).

  • Early Diagnosis: Anti-CCP antibodies can be detected in the blood years before the onset of clinical symptoms, allowing for earlier intervention and treatment, which can significantly improve long-term outcomes.

  • High Specificity: Compared to the Rheumatoid Factor (RF) test, Anti-CCP is much more specific for RA (around 95-98%). A positive result strongly indicates the presence of RA.

  • Disease Severity Predictive Marker: High levels of Anti-CCP are often associated with a more aggressive and destructive form of the disease, indicating a higher risk of joint damage and deformity.

  • Differential Diagnosis: It helps distinguish RA from other types of arthritis or autoimmune conditions with similar symptoms, such as Hepatitis C, Sjögren’s syndrome, or SLE, where RF might be positive but Anti-CCP is usually negative.

When is this test recommended?

  • When a patient presents with symptoms suggestive of inflammatory arthritis, such as persistent joint pain, swelling, stiffness (especially in the morning), and warmth in the small joints of the hands and feet.

  • To confirm a diagnosis of RA, especially when the Rheumatoid Factor (RF) test is negative (seronegative RA).

  • To assess the prognosis and potential severity of the disease in newly diagnosed patients.

  • Note: While highly specific, a negative result does not completely rule out RA, as some patients may be seronegative for both RF and Anti-CCP.

Sample Requirements:

  • Specimen: Serum.

  • Container: Gold Top (SST) or Red Top Tube.

  • Preparation: No fasting is typically required.